These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16611209)

  • 21. The state of dietary supplement adverse event reporting in the United States.
    Gardiner P; Sarma DN; Low Dog T; Barrett ML; Chavez ML; Ko R; Mahady GB; Marles RJ; Pellicore LS; Giancaspro GI
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):962-70. PubMed ID: 18613260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of pharmacovigilance system in Ukraine: first results.
    Stefanov O; Sharayeva M; Jajtchenja V
    Pharmacoepidemiol Drug Saf; 2004 Mar; 13(3):197-9. PubMed ID: 15072120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Adverse events and adverse reactions associated with drugs--important actual spontaneous reporting of the drug event].
    Homma M
    Ryumachi; 1992 Oct; 32(5):429-31. PubMed ID: 1440077
    [No Abstract]   [Full Text] [Related]  

  • 24. [Regional Centers of Pharmacovigilance: a complementary source of efficiency].
    Mazé F; Bégaud B
    Therapie; 1998; 53(4):397-400. PubMed ID: 9806011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Data mining in spontaneous reports.
    Bate A; Edwards IR
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):324-30. PubMed ID: 16611210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse drug reaction reporting--2000: Part 1.
    Sutcliffe H
    CMAJ; 2001 Apr; 164(7):1038, 1042. PubMed ID: 11314437
    [No Abstract]   [Full Text] [Related]  

  • 27. Creating knowledge about adverse drug reactions: a critical analysis of the Danish reporting system from 1968 to 2005.
    Aagaard L; Soendergaard B; Andersen E; Kampmann JP; Hansen EH
    Soc Sci Med; 2007 Sep; 65(6):1296-309. PubMed ID: 17566621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The science of health technology assessment: the safety perspective.
    Shear NH
    Can J Clin Pharmacol; 2001; 8 Suppl A():24A-28A. PubMed ID: 11586375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative signal detection using spontaneous ADR reporting.
    Bate A; Evans SJ
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):427-36. PubMed ID: 19358225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.
    Knopp MV; Balzer T; Esser M; Kashanian FK; Paul P; Niendorf HP
    Invest Radiol; 2006 Jun; 41(6):491-9. PubMed ID: 16763467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The Swiss Centre of Pharmacovigilance].
    Kuhn M; Hartmann K; Gartmann J
    Therapie; 1993; 48(5):465-7. PubMed ID: 8146826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nurses are increasingly involved in pharmacovigilance in Sweden.
    Ulfvarson J; Mejyr S; Bergman U
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there still a role for spontaneous reporting of adverse drug reactions?
    Lexchin J
    CMAJ; 2006 Jan; 174(2):191-2. PubMed ID: 16415466
    [No Abstract]   [Full Text] [Related]  

  • 35. Adverse drug event reporting in intensive care units: a survey of current practices.
    Kane-Gill SL; Devlin JW
    Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medication events: the experience of the Taiwan patient-safety reporting system (TPR).
    Huang LJ; Wung C; Shih CL
    World Hosp Health Serv; 2009; 45(4):19-23. PubMed ID: 20411828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse drug reactions reporting at a referral hospital in Zimbabwe.
    Khoza S; Madungwe I; Nyambayo P; Mthethwa J; Chikuni O
    Cent Afr J Med; 2004; 50(11-12):104-7. PubMed ID: 16615658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
    Shalviri G; Mohammad K; Majdzadeh R; Gholami K
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions.
    Moore N; Thiessard F; Begaud B
    Pharmacoepidemiol Drug Saf; 2005 Apr; 14(4):285-6. PubMed ID: 15782397
    [No Abstract]   [Full Text] [Related]  

  • 40. Adverse drug reactions and avalanches: life at the edge of chaos.
    Frattarelli DA
    J Clin Pharmacol; 2005 Aug; 45(8):866-71. PubMed ID: 16027396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.